Lexicon Pharmaceuticals CEO Lonnel Coats' 2021 pay rises 2% to $3.9M
Lexicon Pharmaceuticals reports 2021 executive compensation
By ExecPay News
Published: April 8, 2022
Lexicon Pharmaceuticals reported fiscal year 2021 executive compensation information on April 8, 2022.
In 2021, five executives at Lexicon Pharmaceuticals received on average a compensation package of $1.8M, which is about the same as previous year.
Average pay of disclosed executives at Lexicon Pharmaceuticals
Lonnel Coats, Chief Executive Officer, received $3.9M in total, which increased by 2% compared to 2020. 50% of Coats' compensation, or $1.9M, was in option awards. Coats also received $439K in bonus, $689K in salary, $838K in stock awards, as well as $13K in other compensation.
For fiscal year 2021, the median employee pay was $234,672 at Lexicon Pharmaceuticals. Therefore, the ratio of Lonnel Coats' pay to the median employee pay was 17 to one.
Jeffrey L. Wade, Chief Financial Officer, received a compensation package of $1.7M, which increased by 1% compared to previous year. 40% of the compensation package, or $653K, was in option awards.
Alan J. Main, Executive Vice President, Innovation and Chemical Sciences, earned $1.3M in 2021, a 1% increase compared to previous year.
Brian T. Crum, General Counsel, received $1.3M in 2021, which increases by 7% compared to 2020.
Craig B. Granowitz, Chief Medical Officer, earned $949K in 2021.
Related executives
Lonnel Coats
Lexicon Pharmaceuticals
Chief Executive Officer
Jeffrey Wade
Lexicon Pharmaceuticals
Chief Financial Officer
Brian Crum
Lexicon Pharmaceuticals
General Counsel
Craig Granowitz
Lexicon Pharmaceuticals
Chief Medical Officer
Alan Main
Lexicon Pharmaceuticals
Executive Vice President, Innovation and Chemical Sciences
You may also like
Source: SEC filing on April 8, 2022.